Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

BSH 2017 | News from the lymphoma special interest group at BSH

Wendy Osborne • 29 Mar 2017
BSH 2017
Follicular Lymphoma T-Cell Lymphoma Rituximab

Wendy Osborne, MBBS, MRCP, FRCPath, from the Newcastle upon Tyne Hospital NHS Foundation Trust, Newcastle upon Tyne, UK, discusses the meeting of the lymphoma special interest group at the 2017 British Society for Haematology (BSH) Annual Scientific Meeting in Brighton, UK. She outlines talks on demystifying T-cell classification, the genetics of follicular lymphoma, and whether to treat asymptomatic follicular lymphoma.

More from Wendy Osborne

2:03
Novel treatment approaches for early-stage DLBCL
Wendy Osborne • 24 Apr 2023
1:20
Improving patient outcomes in CTCL: clinical collaboration and novel agents
Wendy Osborne • 24 Apr 2023
2:19
Session highlights: autoSCT in T-cell lymphoma, classification updates and fertility preservation
Wendy Osborne • 24 Apr 2023
1:01
Pitfalls in the diagnosis of lymphoid malignancies: interpreting PET scans
Wendy Osborne • 24 Apr 2023

Related Videos

1:37
Exciting CAR-T clinical trials in LBCL and FL
Gloria Iacoboni • 15 Apr 2024
1:48
Novel immunotherapy approaches in lymphoma: CAR-T cells, bispecifics & sequencing
Gloria Iacoboni • 15 Apr 2024
1:13
Antibody-drug conjugates for the treatment of lymphoma
Pau Abrisqueta • 5 Apr 2024
3:18
A Phase I study of JBH492, an anti-CCR7 antibody-drug conjugate, in lymphoid malignancies
Pau Abrisqueta • 5 Apr 2024
The content of VJHemOnc is intended for healthcare professionals